TNF-α is a pivotal cytokine involved in the formation and maintenance of granulomas, making TNF-α inhibitors, such as infliximab (a chimeric monoclonal antibody) and adalimumab (a humanized monoclonal antibody), potential treatment options for CS [29]. Here, TNF is linked to Cowden syndrome 1.